BOULDER, Colo., May 25 /PRNewswire-FirstCall/ -- Array BioPharma Inc.
(Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E.
Conway, will speak at the Friedman Billings Ramsey 8th Annual Growth Investor
Conference on June 2 in New York City. The public is welcome to participate
in the conference through a webcast on the Array BioPharma website.
Event: Friedman Billings Ramsey 8th Annual Growth Investor
Presenter: Robert E. Conway, Chief Executive Officer, Array BioPharma
Date: Wednesday, June 2, 2004
Time: 3:30 p.m. Eastern Time
Location: Millennium Broadway Hotel, New York City
About Array BioPharma:
Array BioPharma is creating the next generation of orally active drugs by
integrating the latest advances in chemistry, biology and informatics. Our
drug development pipeline is focused primarily in cancer and inflammatory
disease and includes several promising small molecule drugs that regulate
targets in therapeutically important disease pathways. In addition, Array
collaborates with leading pharmaceutical and biotechnology companies to
design, create and optimize drug candidates across a broad range of
therapeutic areas. Our mission is to be the most efficient inventor of high
quality drug candidates in the pharmaceutical industry. For more information
on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
Tricia Haugeto of Array BioPharma Inc., +1-303-386-1193,
/Web site: http://www.arraybiopharma.com /